tiprankstipranks
Advertisement
Advertisement
Ascentage Pharma Corrects AGM Date Underpinning Equity Incentive Mandate
PremiumCompany AnnouncementsAscentage Pharma Corrects AGM Date Underpinning Equity Incentive Mandate
30d ago
Ascentage Pharma assumed with an Outperform at Oppenheimer
Premium
The Fly
Ascentage Pharma assumed with an Outperform at Oppenheimer
2M ago
Ascentage Pharma announces clinical updates from EHA2026
Premium
The Fly
Ascentage Pharma announces clinical updates from EHA2026
2M ago
Ascentage Pharma presents first dataset of alrizomadlin
PremiumThe FlyAscentage Pharma presents first dataset of alrizomadlin
2M ago
Ascentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target
Premium
Ratings
Ascentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target
3M ago
Ascentage Pharma to Present 17 Hematology Clinical Updates at June 2026 EHA Congress
Premium
Company Announcements
Ascentage Pharma to Present 17 Hematology Clinical Updates at June 2026 EHA Congress
3M ago
Ascentage Pharma Sets March 25 Board Meeting on 2025 Results and Potential Final Dividend
PremiumCompany AnnouncementsAscentage Pharma Sets March 25 Board Meeting on 2025 Results and Potential Final Dividend
5M ago
Ascentage Pharma initiated with a Buy at BTIG
Premium
The Fly
Ascentage Pharma initiated with a Buy at BTIG
5M ago
Ascentage Pharma: Undervalued Long-Term Oncology Leader Backed by Late-Stage Assets Olverembatinib and Lisaftoclax
Premium
Ratings
Ascentage Pharma: Undervalued Long-Term Oncology Leader Backed by Late-Stage Assets Olverembatinib and Lisaftoclax
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100